
==== Front
Am J Physiol Lung Cell Mol Physiol
Am J Physiol Lung Cell Mol Physiol
AJPLUNG
American Journal of Physiology - Lung Cellular and Molecular Physiology
1040-0605
1522-1504
American Physiological Society Rockville, MD

38469627
L-00378-2023
L-00378-2023
10.1152/ajplung.00378.2023
Research Article
targeting-airway-immunity-in-lung-diseaseTargeting Airway Immunity in Lung DiseaseEndoplasmic reticulum stress enhances the expression of TLR3-induced TSLP by airway epithelium
ER STRESS AUGMENTS EPITHELIAL TSLP
https://orcid.org/0000-0002-4947-5918
Pathinayake Prabuddha S. 1
https://orcid.org/0000-0002-6640-0846
Hsu Alan C.-Y. 1 7
Nichol Kristy S. 1
Horvat Jay C. 2
https://orcid.org/0000-0002-4741-3035
Hansbro Philip M. 2 4
https://orcid.org/0000-0001-5676-6126
Wark Peter A. B. 1 3 5 6
1Immune Health Program, Hunter Medical Research Institute and School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia
2Immune Health Program, Hunter Medical Research Institute and School of Biomedical Sciences and Pharmacy, University of Newcastle, Newcastle, New South Wales, Australia
3Department of Respiratory and Sleep Medicine, John Hunter Hospital, Newcastle, New South Wales, Australia
4Faculty of Science, School of Life Sciences, Centre for Inflammation, Centenary Institute, University of Technology Sydney, Sydney, New South Wales, Australia
5School of Medicine, Monash University, Melbourne, Victoria, Australia
6AIRMED Alfred Health , Melbourne, Victoria, Australia
7Signature Research Program in Emerging Infectious Diseases, Duke-National University of Singapore (NUS) Graduate Medical School, Singapore, Singapore
Correspondence: P. S. Pathinayake (Prabuddha.pathinayake@newcastle.edu.au); P. A. B. Wark (Peter.Wark@newcastle.edu.au).
1 5 2024
12 3 2024
12 3 2024
326 5 L618L626
5 12 2023
23 2 2024
6 3 2024
Copyright © 2024 The Authors.
2024
The Authors.
https://creativecommons.org/licenses/by/4.0/ Licensed under Creative Commons Attribution CC-BY 4.0. Published by the American Physiological Society.

Thymic stromal lymphopoietin (TSLP) is an epithelial-derived pleiotropic cytokine that regulates T-helper 2 (Th2) immune responses in the lung and plays a major role in severe uncontrolled asthma. Emerging evidence suggests a role for endoplasmic reticulum (ER) stress in the pathogenesis of asthma. In this study, we determined if ER stress and the unfolded protein response (UPR) signaling are involved in TSLP induction in the airway epithelium. For this, we treated human bronchial epithelial basal cells and differentiated primary bronchial epithelial cells with ER stress inducers and the TSLP mRNA and protein expression was determined. A series of siRNA gene knockdown experiments were conducted to determine the ER stress-induced TSLP signaling pathways. cDNA collected from asthmatic bronchial biopsies was used to determine the gene correlation between ER stress and TSLP. Our results show that ER stress signaling induces TSLP mRNA expression via the PERK-C/EBP homologous protein (CHOP) signaling pathway. AP-1 transcription factor is important in regulating this ER stress-induced TSLP mRNA induction, though ER stress alone cannot induce TSLP protein production. However, ER stress significantly enhances TLR3-induced TSLP protein secretion in the airway epithelium. TSLP and ER stress (PERK) mRNA expression positively correlates in bronchial biopsies from participants with asthma, particularly in neutrophilic asthma. In conclusion, these results suggest that ER stress primes TSLP that is then enhanced further upon TLR3 activation, which may induce severe asthma exacerbations. Targeting ER stress using pharmacological interventions may provide novel therapeutics for severe uncontrolled asthma.

NEW & NOTEWORTHY TSLP is an epithelial-derived cytokine and a key regulator in the pathogenesis of severe uncontrolled asthma. We demonstrate a novel mechanism by which endoplasmic reticulum stress signaling upregulates airway epithelial TSLP mRNA expression via the PERK-CHOP signaling pathway and enhances TLR3-mediated TSLP protein secretion.

ER stress
; severe neutrophilic asthma
; TSLP
; unfolded protein response
; DHAC | National Health and Medical Research Council (NHMRC) 10.13039/501100000925 APP2002953 Alan C-Y HsuDHAC | National Health and Medical Research Council (NHMRC) 10.13039/501100000925 1175134 University of Technology Sydney (UTS) 10.13039/501100001775 P.M.H.Call for PapersTrue
==== Body
pmcINTRODUCTION

Thymic stromal lymphopoietin (TSLP) is an innate IL-7-like cytokine that is predominantly expressed in the epithelium of the lung, gut, and skin (1), though it is also expressed by mast cells, airway smooth muscle cells, fibroblasts, dendritic cells, trophoblasts, and neoplastic cells (2). TSLP strongly activates antigen-presenting dendritic cells (DCs) and promotes the differentiation of naive human CD4+ T cells to T-helper type-2 (Th2) cells (3–5). It also regulates DC-mediated CD4+ T-cell homeostasis by expanding autologous CD4+ T-cell populations (6). Moreover, TSLP suppresses the activity of regulatory T cells (Tregs) in the lungs. It directly and selectively reduces IL-10 production by Treg in both healthy and asthmatic patients but more potently in asthmatics (7). It also suppresses antigen-specific Tregs (8) suggesting a role for TSLP in suppressing allergen tolerance in the airways. In this context, it is increasingly thought to play an important role in promoting airway inflammation in asthma. Increased expression of TSLP has been found in bronchial mucosa and bronchoalveolar lavage fluid (BALF) of severe asthma patients (9). The TSLP concentration in BALF of those patients was correlated with poor lung function and the dose of corticosteroids used, suggesting that this cytokine is a potential biomarker of severe uncontrolled asthma (10).

Various stimulants such as TLR ligands, Nod2 ligands, viral, bacterial and fungal infections, allergens, helminths, environmental pollutants such as diesel exhaust, and cigarette smoke can stimulate TSLP secretion in the lungs (2). In DCs, TSLP secretion induced by Candida albicans and β-glucans is enhanced by signals emanating from the endoplasmic reticulum (ER) stress response, specifically the unfolded protein response (UPR) sensors, inositol-requiring transmembrane kinase/endonuclease (IRE)-1, and protein kinase R-like ER kinase (PERK). However, ER stress alone was not sufficient to induce TSLP (11). The UPR is an adaptive response when cells undergo ER stress due to physiological demand or aberrations in protein folding in the ER (12). The UPR activates a complex signaling cascade that involves the activation of various transcription factors. C/EBP homologous protein (CHOP) is a multifunctional transcription factor that activates the UPR and induces apoptosis and inflammatory responses in cells (13). CHOP is involved in IL-1β production in macrophages (14) and IL-23 in DCs (15) and also plays an important role as a gene transcription enhancer or inhibitor. It can form a heterodimer with C/EBP family transcription factors and activate the expression of certain activator protein (AP)-1-targeted genes (16). It can also inhibit certain genes by dimerizing with C/EBP and liver-enriched transcriptional activator protein (LAP) (17).

Here, we demonstrate a novel mechanism of TSLP mRNA induction in the airway epithelium via ER stress/UPR-induced CHOP signaling. We show that ER stress also enhances TSLP protein secretion induced by TLR3 agonists such as polyinosinic:polycytidylic acid (poly I:C) in the airway epithelium. Furthermore, we provide evidence for an association between ER stress and TSLP expression in clinical bronchial biopsies from severe asthma patients, in particular those with neutrophilic inflammation. These data define a novel mechanism underpinning increased TSLP expression in the asthmatic epithelium in severe asthma and during virus-induced acute asthma.

MATERIALS AND METHODS

Cell Culture

BEGM media.

To prepare BEGM complete media, bronchial epithelial cell (BEC) growth medium (BEGM; Lonza) supplemented with bovine pituitary extract (BPE), insulin, gentamicin sulfate (GA-1000), retinoic acid, transferrin, tri-iodothyronine (T3), epinephrine, rhEGF, hydrocortisone, penicillin/streptomycin (2%), and amphotericin B (fungizone, 1%). To prepare BEGM minimal media, penicillin/streptomycin (2%), amphotericin B (fungizone, 1%), insulin-transferrin-sodium (ITS, 1%; Sigma), and linoleic acid-albumin from bovine serum albumin (0.5%; Sigma) were added into bronchial epithelial basal medium (BEBM).

Air-liquid interface media.

Air-liquid interface (ALI) initial media comprised 50% BEBM-50% DMEM containing hydrocortisone, bovine insulin, epinephrine, transferrin (all 0.1%), bovine pituitary extract (0.4%) (all from Lonza) and ethanolamine (final concentration 80 μM), MgCl2 (final concentration 0.3 mM), MgSO4 (final concentration 0.4 mM), bovine serum albumin (final concentration 0.5 mg/mL), amphotericin B (final concentration 250 μg/mL), all-trans retinoic acid (30 ng/mL), and penicillin/streptomycin (2%) with rhEGF (10 ng/mL). For ALI final media, recombinant human epidermal growth factor (rhEGF) concentration was changed to 0.5 ng/mL.

BCi-NS1.1 cell line.

Normal airway epithelium-derived basal cell line BCi-NS1.1 cells (18) were cultured in BEGM complete media and maintained in T25 cell culture flasks. For stimulations, cells were seeded in 24-well cell culture plates (1 × 105 cells/well) and used at 80% confluent.

ALI cultures.

Primary (p)BECs were obtained from patients with asthma and control subjects bronchoscopically (19). All subjects gave written informed consent, and the study protocol was approved by the Hunter New England Human Research Ethics Committee (05/08/10/3.09). pBECs were grown in BEGM complete media in submerged monolayer culture first and then seeded at 2 × 105 cells in transwells in a 12-well plate (Corning) with ALI-initial media until confluent (at least 3 days in both apical and basal compartments). Once confluent, media was changed to ALI final media by changing rhEGF concentration until day 21 after initial seeding.

Patient demographics for pBECs.

Table 1 shows clinical characteristics and inflammatory cell profiles of healthy controls and participants with asthma who were recruited for bronchial brushing collection. Features of participants with asthma were categorized based on clinical severity following GINA guidelines.

Table 1. Clinical characteristics and inflammatory cell profiles of healthy controls and participants with asthma who were recruited for bronchial brushing collection

	Healthy	Severe Asthma	
Participants, n	5	5	
Age, yr (median, IQR)	64 (63–64)	53 (50–67)	
Sex, n (%)	Male 1 (20%), female 4 (80%)	Male 1 (20%), female 4 (80%)	
Atopy, n (%)	1 (20%)	4 (80%)	
FEV1 % predicted, median (IQR)	103 (100–107)	57 (45–61)	
FEV1/FVC %, median (IQR)	78.8 (78.47–81.38)	49.5 (46.3–60)	
ICS dose, µg budesonide dose/day, median (IQR)	0	2,000 (1,600–2,000)	
ACQ5, median (IQR)	NA	3.5 (2.75–4.25)	
Neutrophils %, median (IQR)	21.75 (3–25.75)	63.1 (44.2–73.8)	
Eosinophils %, median (IQR)	0.25 (0–1)	5.5 (1.25–13.25)	
Macrophages %, median (IQR)	38.25 (36.5–39.75)	12.75 (9–27.25)	
Values are median (IQR). Features of participants with asthma were categorized based on clinical severity following GINA guidelines. %, percentage; ACQ, asthma control questionnaire; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; ICS, inhaled corticosteroids; IQR, interquartile range; n, number; yr, years.

Bronchial biopsy sample collection and analysis.

cDNA from endobronchial biopsies collected for our previous study that elucidated evidence of ER stress in asthmatic airways was used for correlation analysis. For patient clinical parameters and sample collection details, see Pathinayake et al. (20).

Cell culture treatments.

ER stress was chemically induced in cell cultures by adding tunicamycin (2 µg/mL; Merk Millipore) or thapsigargin (1 µM; Merk Millipore) into BEGM minimal media for the indicated time points. A total of 10 µg/mL polyinosinic:polycytidylic acid (poly I:C) was used to induce TSLP induction in BECs.

Gene knockdown.

Small interfering (si)RNAs were used for gene silencing. XBP1-silencer siRNA (200 nM, sc-38627; Santa Cruz Biotechnology), CHOP-stealth RNAi siRNA (100 nM, VHS40605; Life Technologies, Australia), IRE1α-silencer-select siRNA (10 nM, s200430; Life Technologies, Australia), ATF6-silencer-select siRNA (10 nM, s223543; Life Technologies, Australia), PERK-silencer-select siRNA (10 nM, s18102; Life Technologies, Australia), and CEBPB silencer-select siRNA (10 nM, s2891; Life Technologies, Australia) with lipofectamine 3000 (ThermoFisher Scientific) were used to knockdown mRNA expression. At 12 h post transfection, media was replenished and at 24 h post transfection cells were treated with interventions.

mRNA extraction and qPCR.

Total mRNA was extracted from cells lysed in 350 µL of RLT buffer using RNeasy mini kit (Qiagen, Germany) following the manufacturer’s instructions and quantified using a nano-drop 2000 spectrophotometer (ThermoFisher Scientific). A total of 200 ng of mRNA from each sample was used to produce cDNA using a high-capacity cDNA reverse transcription kit (Applied Biosystems). Various genes of interest were quantified by qPCR using TaqMan gene expression assays (ThermoFisher Scientific, Australia) and normalized to the 18S housekeeping gene. Results were calculated using 2–ΔΔCt (where Ct is the threshold cycle) relative to the mean ΔCt of the healthy control group as described before (21).

ELISA.

TSLP protein in cell culture supernatants was measured using a high-sensitivity (3.3–800 pg/mL) human TSLP ELISA kit (ab155444) following the manufacturer’s instructions. Briefly, standards and samples were added into wells and incubated (2.5 h) to bind TSLP to the immobilized antibody. Wells were washed and biotinylated anti-human TSLP antibody was added. After washing away the unbound biotinylated antibody, horseradish peroxidase (HRP)-conjugated streptavidin was added. Wells were again washed, and TMB substrate solution was added. Stop solution was added to stop color development and intensity was measured (450 nm).

Statistical Analysis

Data were analyzed using GraphPad Prism 9.0.0 software. Multiple comparisons between groups were analyzed with an appropriate test for normally distributed data with ANOVA, followed by post hoc analysis (Dunnett’s or Dunn’s test). Two-group comparisons were analyzed with an unpaired t test. Correlation analyses were performed using Spearman’s rank test. Statistical significance of P < 0.05 was accepted with a 95% confidence interval.

RESULTS

TSLP Gene Expression Is Upregulated in BECs by Chemically Induced ER Stress

To examine if ER stress can induce epithelial TSLP expression, BCi-NS1.1 cells were treated with tunicamycin and the mRNA expression of TSLP and key ER stress/UPR markers (BiP, XBP1s, CHOP) were measured time-dependently by qPCR (Fig. 1). Tunicamycin significantly upregulated mRNA expression of TSLP by 6 h post treatment that continued to be elevated until 24 h and at 36 h the mRNA fold change declined (Fig. 1A). It also increased each of the key ER stress and the UPR-related markers as early as 6 h post treatment. mRNA of BiP and CHOP mRNA were constantly expressed until 36 h (Fig. 1, B and C). mRNA expression of XBP1s peaked at 6 h and gradually decreased by 24 h (Fig. 1D).

Figure 1. ER stress induces TSLP mRNA expression in bronchial epithelial cells. BCi-NS1.1 cells (n = 3) were treated with tunicamycin 2 µg/mL to induce ER stress and UPR markers, and TSLP gene expression was measured by qPCR. ER stress upregulates TSLP (A), BiP (B), CHOP (C), and XBP1s (D) gene expression in a time-dependent manner. Differences between the groups were assessed using one-way analysis of variance (ANOVA), with Dunnett’s multiple comparison test. *P ≤ 0.05. ER, endoplasmic reticulum; qPCR, quantitative PCR; TSLP, thymic stromal lymphopoietin; UPR, unfolded protein response.

PERK Signaling in the UPR Is Important for ER Stress-Induced Epithelial TSLP mRNA Expression

To define which signaling arm of the UPR is important for ER stress-induced TSLP induction, we selectively knocked down the three main branches of the UPR—IRE1a, PERK, and ATF6—using specific siRNAs. After 36 h of siRNA transfection, cells were challenged with tunicamycin for 12 h and harvested for qPCR. All siRNAs significantly knocked down their targets (Fig. 2, A–C). Notably, only PERK knockdown affected tunicamycin-induced TSLP mRNA induction (Fig. 2D) suggesting that ER stress-induced TSLP mRNA expression is regulated through PERK signaling.

Figure 2. ER stress-induced TSLP mRNA expression is mainly regulated through the PERK signaling pathway. The mRNA expression of IRE1α, ATF6, and PERK in BCi-NS 1.1 cells was knocked down using target-specific silencer-select siRNA (n = 3). At 36 h post knockdown, cells were challenged with tunicamycin for 12 h and mRNA expression of IRE1α (A), ATF6 (B), and PERK (C) was measured by qPCR. D: mRNA expression of TSLP was measured by qPCR in IRE1α, ATF6, and PERK knockdown cells following tunicamycin challenge. Differences between the groups were assessed using one-way analysis of variance (ANOVA), with Dunnett’s multiple comparison test. *P ≤ 0.05. ER, endoplasmic reticulum; qPCR, quantitative PCR; TSLP, thymic stromal lymphopoietin.

ER Stress-Induced CHOP Expression Is Crucial for Epithelial TSLP mRNA Induction in ER Stress

Since XBP1s and CHOP are important transcription factors in UPR signaling, and as we have observed that ER stress-induced TSLP gene induction is mainly regulated through the PERK arm of the UPR, we examined if these transcription factors are involved in TSLP expression in airway epithelial cells. To demonstrate, we knocked down XBP1s and CHOP expression with siRNA and the expression of TSLP with or without tunicamycin challenge was measured by qPCR. XBP1s knockdown (Fig. 3A) did not have any significant effect (Fig. 3B). Knockdown of CHOP (Fig. 3C) significantly reduced tunicamycin-induced TSLP mRNA expression (Fig. 3D). Collectively, these results show that the PERK-CHOP signaling axis is crucial for ER stress-induced epithelial TSLP gene induction.

Figure 3. CHOP expression is crucial for the induction of TSLP mRNA expression in ER stress. The mRNA expression of XBP1 and CHOP was knocked down using target-specific silencer-select siRNA (n = 3). At 36 h post knockdown, cells were challenged with tunicamycin for 12 h and mRNA expression of XBP1 (A), CHOP (C), and TSLP (B and D) was measured by qPCR. Differences between the groups were assessed using Student’s t test. *P ≤ 0.05. ER, endoplasmic reticulum; TSLP, thymic stromal lymphopoietin.

CHOP Is a Transcription Enhancer for AP-1 to Induce TSLP Expression in the Airway Epithelium

Since our data show that CHOP is crucial for ER stress-induced TSLP mRNA expression in BECs, we assessed if CHOP can act as a transcription factor for TSLP induction. We first screened the complete nucleotide sequence of TSLP for matches for the consensus recognition sequence for CHOP. However, we did not find any matching consensus sequence suggesting that CHOP cannot directly act as a transcription factor for TSLP (Fig. 4A). CHOP cannot form homodimers but forms stable heterodimers with C/EBP family proteins and is known to act as a transcription factor (22). CHOP also forms a heterodimer with CCAAT enhancer binding protein β (CEBPB) and components of the AP-1 protein. Thus, we assessed the consensus recognition sites for CEBPB and found them in the TSLP nucleotide sequence. AP-1 is a known regulator of TSLP transcription (23), can form a heterodimer with CHOP, and activates the promoters of selected genes such as somatostatin, JunD, and collagenase (16). Using specific siRNA knockdown of the CEBPB gene and an AP-1-specific inhibitor T-5224, we determined their role in ER stress-induced TSLP gene transcription (Fig. 4B). AP-1 inhibition significantly reduced tunicamycin-induced TSLP mRNA expression, comparable to the effect of CHOP siRNA knockdown. Knockdown of CEBPB did not affect tunicamycin-induced TSLP mRNA expression. These results show that the CHOP-AP-1 complex, but not CEBPB, is crucial for ER stress-induced TSLP gene transcription.

Figure 4. CHOP-AP1 complex is crucial for ER stress-induced TSLP gene induction in the airway epithelium. A: consensus recognition sequences for CHOP ( ATTGCATCAT) and CEBPB (T[TG]NNGNAA[TG]) were screened within the complete nucleotide sequence of TSLP. B: mRNA expression of CEBPB was knocked down using siRNA, and AP-1 expression was inhibited using T-5224 (n = 3). Cells were then treated with tunicamycin and the mRNA expression of TSLP was measured by qPCR. Differences between the groups were assessed using one-way analysis of variance (ANOVA), with Dunnett’s multiple comparison test. *P ≤ 0.05. ER, endoplasmic reticulum; qPCR, quantitative PCR; TSLP, thymic stromal lymphopoietin.

ER Stress Alone Does Not Induce TSLP Protein in BECs but Synergically Enhances Its Production by Poly I:C

Our mRNA expression data showed significant induction of TSLP expression with chemical-induced ER stress in BECs. We next examined if this translated into protein. To do this, we measured secreted TSLP protein in cell culture supernatants of BCi-NS1.1 cells challenged with tunicamycin or thapsigargin. Intriguingly, we did not find any detectable levels of TSLP in the culture supernatants (Fig. 5A). As ER stress activates signaling pathways that inhibit protein export and secretion, we measured TSLP protein in cell lysate by ELISA to determine if TSLP protein is translated but then trapped inside the cells. However, we could not detect any TSLP protein in the whole cell lysate even using a high-sensitivity ELISA kit. To assess if ER stress-induced TSLP mRNA induction can enhance the TSLP protein secretion by other known TSLP stimulants in the airway epithelium, we treated BCi-NS1.1 cells with poly I:C alone or together with tunicamycin or thapsigargin for 48 h and the secreted TSLP protein level was measured by ELISA. After 48 h of challenge, poly I:C together with tunicamycin or thapsigargin resulted in the production of significantly higher levels of TSLP protein compared with poly I:C alone (Fig. 5B). To determine if knockdown of UPR signaling arms affects poly IC + tunicamycin-induced TSLP protein production, the gene expression of PERK, IRE1α, and ATF6 in BCi-NS 1.1 cells was knocked down using siRNA. Cells were then treated with poly IC along with tunicamycin and after 48 h secreted TSLP was measured by ELISA (Fig. 5C). Our data show that knockdown of PERK gene slightly reduced poly IC + tunicamycin-induced TSLP protein but not statistically significant.

Figure 5. ER stress alone does not induce but synergically increases the production of TSLP protein via TLR3 signaling. A: BCi-NS1.1 cells were challenged with various ER stress inducers and poly:IC as a positive control (n = 6). After 48 h post challenge, TSLP protein levels in cell supernatants and lysates were measured by ELISA. B: BCi-NS1.1 cells were challenged with various ER stress inducers with or without poly:IC (n = 9) and after 48 h the TSLP protein level in the supernatant was measured by ELISA. C: to determine the effect of UPR signaling arms on poly IC-induced TSLP protein expression, IRE1α, ATF6, and PERK genes were knocked down using target-specific silencer-select siRNA in BCi-NS1.1 cells (n = 5) and treated with poly IC together with tunicamycin. After 48 h, secreted TSLP was measured by ELISA. Differences between the groups were assessed using one-way analysis of variance (ANOVA), with Dunnett’s multiple comparison test. *P ≤ 0.05. ER, endoplasmic reticulum; TSLP, thymic stromal lymphopoietin.

ER Stress Induces TSLP mRNA Expression in Differentiated pBECs and Clinically Correlates with Severe Neutrophilic Asthma

Single-cell-transcriptomic data from lung atlas data suggest that airway epithelial basal cells are the predominant source of TSLP production (24). This determined our choice of BCi-NS 1.1 minimally immortalized bronchial epithelial basal cell line, grown in submerged culture to reflect this basal cell phenotype. To validate our findings, we treated pBEC-ALI cultures from asthma patients and control subjects with ER stress inducers (patients’ demographic details are displayed in Table 1). Similar to our basal cell line data, pBECs from both control subjects (Fig. 6A) and patients with severe asthma (Fig. 6B) (n = 5) had a significant increase in TSLP mRNA induction upon tunicamycin challenge. To assess if increased ER stress is associated with increased expression of TSLP in clinical samples, a correlation analysis was performed measuring the mRNA expression of PERK and TSLP in bronchial biopsies from patients with severe neutrophilic (n = 8) and eosinophilic asthma (n = 10) (patient’s demographic details are displayed in Table 2). Increased ER stress and TSLP mRNA positively and significantly correlate in severe neutrophilic asthma (Fig. 6C) but did not reach significance in those with severe eosinophilic asthma (Fig. 6D).

Figure 6. ER stress induces TSLP in primary bronchial epithelial cells (pBECs) and correlates with TSLP expression in severe neutrophilic asthma. pBECs-ALI cultures from control subjects (n = 5; A) and patients with asthma (n = 5; B) were challenged with tunicamycin, and TSLP mRNA induction was measured by qPCR. The association between PERK and TSLP and mRNA expression in endobronchial biopsy samples from patients with neutrophilic (n = 8; C) and eosinophilic asthma (n = 10; D) was assessed by Spearman’s correlation analysis. *P ≤ 0.05. ER, endoplasmic reticulum; qPCR, quantitative PCR; TSLP, thymic stromal lymphopoietin.

Table 2. Clinical characteristics and inflammatory cell profiles of healthy controls and severe asthma patients in whom endobronchial biopsies were collected

	Neutrophilic Asthma	Eosinophilic Asthma	
Subjects, n	8	10	
Age, yr, mean (SD)	61.9 (10.94)	56.6 (9.58)	
Males/females, n	4/4	4/6	
Atopy, %	70	70	
FEV1 % predicted, median (SD)	66.5 (18.79)	74.5 (17.5)	
FEV1/FVC%, median (SD)	62 (6.2)	67 (7.33)	
ICS dose, as µg budesonide dose/day, median (IQR)	1,000 (1,000–1,000)	900 (700–1,000)	
ACQ average, median (IQR)	2.3(1.765–2.65)	2.3(1.55–2.815)	
Neutrophils %, median (IQR)	88.51 (85.25–91.88)	24.27 (15.06–26)	
Eosinophils %, median (IQR)	1.05 (0.56–1.62)	29.57 (14.4–42.5)	
Macrophages %, median (IQR)	8.9 (5.87–12.06)	31.5 (21.3–39.31)	
Values are median (IQR). Features of severe asthma participants were further categorized based on inflammatory phenotypes. %, percentage; ACQ, asthma control questionnaire; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; ICS, inhaled corticosteroids; IQR, interquartile range; n, number; yr, years.

DISCUSSION

TSLP is an epithelial-derived cytokine that initiates potent inflammatory responses implicated in the pathogenesis of severe asthma (25, 26). Recent findings in clinical trials with anti-TSLP monoclonal antibody (tezepelumab) in uncontrolled severe asthma patients showed a significant reduction in asthma exacerbations and improved symptoms, an effect that was not confined to participants with eosinophilic airway inflammation (27). This suggests that there is a dominant role for TSLP in corticosteroid-refractory severe asthma. Other clinical benefits were associated with reduced levels of a broad spectrum of Th2 cytokines, and baseline biomarkers (e.g., blood eosinophils, IgE, FeNO) were observed across a range of severe asthma phenotypes (28). This suggests that anti-TSLP elicits broad inhibitory effects on pathways that are key to inflammation in asthma rather than on narrower inhibition of individual downstream factors. The airway epithelium in asthma is highly modified, fragile, and activated (26). Chronic inflammation, persistent cellular stress, and the fragile nature of the asthmatic epithelium result in constant damage and repair that lead to high metabolic turnover (29–31). These factors activate the UPR and some pathways of the integrated stress response. We and others previously showed that ER stress and the UPR are associated with severe corticosteroid-resistant neutrophilic and eosinophilic asthma (12, 32–34). We have also shown robust evidence of altered ER stress and the UPR signaling in an array of clinical samples of asthma and its correlation with disease severity and inflammatory phenotypes (20). Importantly, we found that these ER stress and the UPR markers are more confined to metabolically active cells with greater turnover such as the airway epithelium in asthmatic lung biopsies (20).

Our findings in the current study demonstrate that ER stress-induced activated UPR signaling contributes to TSLP mRNA induction in BECs and enhances the TSLP secretion induced by TLR3 agonists. This could be a novel mechanism that explains upregulated TSLP secretion in the asthmatic airways and consequent asthma exacerbations. The underlying ER stress in the asthmatic airway epithelium may then enhance TSLP secretion induced by respiratory viruses and allergens that trigger TLR3 signaling. Indeed, it has been shown that rhinovirus infection in the asthmatic airways exaggerates TSLP secretion compared with normal airways (3).

In this study, interestingly, we found that ER stress alone significantly induces TSLP gene expression but not protein release. Protein translation repression mechanisms induced by ER stress via eIF2α phosphorylation may suppress the translation of TSLP mRNA induced by ER stress. However, this process was not affected or was overcome when ER stress occurred along with TLR3 activation. Under ER stress conditions, extensive remodeling in translatomes occurs and translation of nearly 50% of mRNA is affected; however, certain mRNAs are resistant to this translational repression (35). Some transcription factors including subunits of AP-1 (Jun and Fos) increase under ER stress (35). Whether PERK-CHOP-induced TSLP mRNA undergoes this eIF2α-initiated translational repression is unknown. Potentially, TLR3-induced TSLP mRNA is resistant to this process and enhanced via transcription factor upregulation during ER stress. Furthermore, ER stress has been shown to induce NF-κB activity and enhance TLR signaling (36, 37). Further studies to elucidate the mechanisms underpinning ER stress upregulation of TLR3-induced TSLP would be required.

ER stress also enhances C. albicans- and β‐glucan-induced TSLP secretion in DCs. One study demonstrated that fungus-induced TSLP requires an integration of signals from dectin‐1, the IL‐1 receptor, and ER stress signaling pathway particularly IRE1-α and PERK though not CHOP (11). In contrast, our study shows that the PERK-CHOP signaling pathway is important in ER stress-induced TSLP gene induction in airway epithelial cells, though it requires priming signals such as TLR3 activation to produce and release TSLP protein. In consistent with this, knockdown of PERK signaling arm marginally reduced the poly IC + tunicamycin-induced TSLP protein secretion (Fig. 5C) but was not statistically significant. This could be due to the CHOP gene expression, which is the main factor involved in ERS-induced TSLP, and could still be activated via multiple ERS arms although mainly regulated through PERK signaling (38). Moreover, TLR3-induced TSLP production in airway epithelial cells is also shown to be induced in an IRF3-NF-κB-dependent manner and synergically enhanced by Th2 cytokines such as IL-4 and IL-13 explaining higher TSLP secretion in asthmatic airways (39). Whether ERS enhances IRF3-NF-κB and contributes to enhance the TLR3-induced TSLP protein is unknown and needs future investigation.

We previously showed evidence of increased ER stress and UPR markers in the airways of asthmatic patients, particularly in severe eosinophilic and neutrophilic asthma (20). We found these upregulated markers in BALF, sputum, and endobronchial biopsies taken from severe asthma patients. In this study, we show that induced ER stress, via the PERK signaling pathway, correlates with increased TSLP gene expression in endobronchial biopsy samples of patients with severe neutrophilic asthma, where we mostly find severe refractory disease (40). Upregulated and persistent ER stress in neutrophilic asthma airways may prime TSLP that is then enhanced further upon TLR3 activation such as by respiratory virus infections and contributes to severe exacerbations, leading to further neutrophilic airway inflammation and a state that is relatively refractory to corticosteroid treatment (41). Treatments that suppress ER stress in the airways such as pharmacological chaperones may provide novel therapeutic avenues to reduce TSLP release, making them a relatively low-cost potential treatment for severe asthma or potentially in the setting of acute asthma exacerbations triggered by virus infections, in uncontrolled asthma.

DATA AVAILABILITY

The data that support the findings of this study are openly available at https://doi.org/10.6084/m9.figshare.24047154.

GRANTS

This work was funded by the National Health and Medical Research Council (NHMRC) of Australia (APP2002953). P.M.H. is funded by Fellowship/Investigator grants from the NHMRC (1175134) and University of Technology Sydney.

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the authors.

AUTHOR CONTRIBUTIONS

P.S.P., A.C.-Y.H., and P.A.B.W. conceived and designed research; P.S.P. and K.S.N. performed experiments; P.S.P. and K.S.N. analyzed data; P.S.P., A.C.-Y.H., J.C.H., and P.A.B.W. interpreted results of experiments; P.S.P. prepared figures; P.S.P. and A.C.-Y.H. drafted manuscript; P.S.P., A.C.-Y.H., K.S.N., J.C.H., P.M.H., and P.A.B.W. edited and revised manuscript; J.C.H., P.M.H., and P.A.B.W. approved final version of manuscript.

ACKNOWLEDGMENTS

Graphical abstract was created with a licensed version of BioRender.com.
==== Refs
REFERENCES

1. Liu YJ, Soumelis V, Watanabe N, Ito T, Wang YH, Malefyt Rde W, Omori M, Zhou B, Ziegler SF. TSLP: an epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation. Annu Rev Immunol 25 : 193–219, 2007. doi:10.1146/annurev.immunol.25.022106.141718. 17129180
2. Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 61 : 3–17, 2012. doi:10.2332/allergolint.11-RAI-0395. 22270071
3. Al-Shami A, Spolski R, Kelly J, Keane-Myers A, Leonard WJ. A role for TSLP in the development of inflammation in an asthma model. J Exp Med 202 : 829–839, 2005. doi:10.1084/jem.20050199. 16172260
4. Liu Y-J. TSLP in epithelial cell and dendritic cell cross talk. Adv Immunol 101 : 1–25, 2009. doi:10.1016/S0065-2776(08)01001-8. 19231591
5. Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B, Gilliet M, Ho S, Antonenko S, Lauerma A, Smith K, Gorman D, Zurawski S, Abrams J, Menon S, McClanahan T, de Waal-Malefyt Rd R, Bazan F, Kastelein RA, Liu YJ. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 : 673–680, 2002. doi:10.1038/ni805. 12055625
6. Watanabe N, Hanabuchi S, Soumelis V, Yuan W, Ho S, de Waal Malefyt R, Liu YJ. Human thymic stromal lymphopoietin promotes dendritic cell-mediated CD4+ T cell homeostatic expansion. Nat Immunol 5 : 426–434, 2004. doi:10.1038/ni1048. 14991051
7. Nguyen KD, Vanichsarn C, Nadeau KC. TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway. Allergy Asthma Clin Immunol 6 : 4, 2010. doi:10.1186/1710-1492-6-4. 20230634
8. Lei L, Zhang Y, Yao W, Kaplan MH, Zhou B. Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells. J Immunol 186 : 2254–2261, 2011. doi:10.4049/jimmunol.1002503. 21242516
9. Ying S, O’Connor B, Ratoff J, Meng Q, Fang C, Cousins D, Zhang G, Gu S, Gao Z, Shamji B, Edwards MJ, Lee TH, Corrigan CJ. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol 181 : 2790–2798, 2008. doi:10.4049/jimmunol.181.4.2790. 18684970
10. Li Y, Wang W, Lv Z, Li Y, Chen Y, Huang K, Corrigan CJ, Ying S. Elevated expression of IL-33 and TSLP in the airways of human asthmatics in vivo: a potential biomarker of severe refractory disease. J Immunol 200 : 2253–2262, 2018. doi:10.4049/jimmunol.1701455. 29453280
11. Elder MJ, Webster SJ, Williams DL, Gaston JSH, Goodall JC. TSLP production by dendritic cells is modulated by IL-1β and components of the endoplasmic reticulum stress response. Eur J Immunol 46 : 455–463, 2016. doi:10.1002/eji.201545537. 26573878
12. Pathinayake PS, Hsu AC-Y, Waters DW, Hansbro PM, Wood LG, Wark PAB. Understanding the unfolded protein response in the pathogenesis of asthma. Front Immunol 9 : 175, 2018. doi:10.3389/fimmu.2018.00175. 29472925
13. Nishitoh H. CHOP is a multifunctional transcription factor in the ER stress response. J Biochem 151 : 217–219, 2011. doi:10.1093/jb/mvr143. 22210905
14. Endo M, Mori M, Akira S, Gotoh T. C/EBP homologous protein (CHOP) is crucial for the induction of caspase-11 and the pathogenesis of lipopolysaccharide-induced inflammation. J Immunol 176 : 6245–6253, 2006. doi:10.4049/jimmunol.176.10.6245. 16670335
15. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, Gaston JS. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci USA 107 : 17698–17703, 2010. doi:10.1073/pnas.1011736107. 20876114
16. Ubeda M, Vallejo M, Habener JF. CHOP enhancement of gene transcription by interactions with Jun/Fos AP-1 complex proteins. Mol Cell Biol 19 : 7589–7599, 1999. doi:10.1128/MCB.19.11.7589. 10523647
17. Ron D, Habener JF. CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6 : 439–453, 1992. doi:10.1101/gad.6.3.439. 1547942
18. Walters MS, Gomi K, Ashbridge B, Moore MAS, Arbelaez V, Heldrich J, Ding B-S, Rafii S, Staudt MR, Crystal RG. Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity. Respir Res 14 : 135–135, 2013. doi:10.1186/1465-9921-14-135. 24298994
19. National Institutes of Health National Heart, Lung, and Blood Institute and National Institute of Allergy and Infectious Diseases, American Academy of Allergy and Immunology, American College of Chest Physicians, and American Thoracic Society. Workshop summary and guidelines: Investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases. J Allergy Clin Immunol 88 : 808–814, 1991. doi:10.1016/0091-6749(91)90189-u. 1955640
20. Pathinayake PS, Waters DW, Nichol KS, Brown AC, Reid AT, Hsu AC-Y, Horvat JC, Wood LG, Baines KJ, Simpson JL, Gibson PG, Hansbro PM, Wark PAB. Endoplasmic reticulum-unfolded protein response signalling is altered in severe eosinophilic and neutrophilic asthma. Thorax 77 : 443–451, 2021. doi:10.1136/thoraxjnl-2020-215979. 34510013
21. Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2^(-delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath 3 : 71–85, 2013. 25558171
22. Ubeda M, Wang XZ, Zinszner H, Wu I, Habener JF, Ron D. Stress-induced binding of the transcriptional factor CHOP to a novel DNA control element. Mol Cell Biol 16 : 1479–1489, 1996. doi:10.1128/MCB.16.4.1479. 8657121
23. Redhu NS, Saleh A, Halayko AJ, Ali AS, Gounni AS. Essential role of NF-κB and AP-1 transcription factors in TNF-α-induced TSLP expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 300 : L479–L485, 2011. doi:10.1152/ajplung.00301.2009. 21148792
24. Sikkema L, Ramírez-Suástegui C, Strobl DC, Gillett TE, Zappia L, Madissoon E; Lung Biological Network Consortium, , et al . An integrated cell atlas of the lung in health and disease. Nat Med 29 : 1563–1577, 2023. doi:10.1038/s41591-023-02327-2. 37291214
25. Hansbro PM, Kaiko GE, Foster PS. Cytokine/anti-cytokine therapy - novel treatments for asthma? Br J Pharmacol 163 : 81–95, 2011. doi:10.1111/j.1476-5381.2011.01219.x. 21232048
26. Hallstrand TS, Hackett TL, Altemeier WA, Matute-Bello G, Hansbro PM, Knight DA. Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin Immunol 151 : 1–15, 2014. doi:10.1016/j.clim.2013.12.003. 24503171
27. Corren J, Parnes JR, Wang L, Mo M, Roseti SL, Griffiths JM, van der Merwe R. Tezepelumab in adults with uncontrolled asthma. N Engl J Med 377 : 936–946, 2017. doi:10.1056/NEJMoa1704064. 28877011
28. Parnes JR, Molfino NA, Colice G, Martin U, Corren J, Menzies-Gow A. Targeting TSLP in asthma. J Asthma Allergy 15 : 749–765, 2022. doi:10.2147/JAA.S275039. 35685846
29. Campbell A, Vignola A, Chanez P, Couret I, Michel FB, Bousquet J, Godard PH. Functional assessment of viability of epithelial cells. Comparison of viability and mediator release in healthy subjects and asthmatics. Chest 101 : 25s–27s, 1992. 1541195
30. Montefort S, Roche WR, Holgate ST. Bronchial epithelial shedding in asthmatics and non-asthmatics. Respir Med 87 , Suppl B : 9–11, 1993. doi:10.1016/S0954-6111(06)80346-X. 8234974
31. Ravi A, Goorsenberg AWM, Dijkhuis A, Dierdorp BS, Dekker T, van Weeghel M, Sabogal Piñeros YS, Shah PL, ten Hacken NHT, Annema JT, Sterk PJ, Vaz FM, Bonta PI, Lutter R. Metabolic differences between bronchial epithelium from healthy individuals and patients with asthma and the effect of bronchial thermoplasty. J Allergy Clin Immunol 148 : 1236–1248, 2021. doi:10.1016/j.jaci.2020.12.653. 33556463
32. Kim SR, Kim DI, Kang MR, Lee KS, Park SY, Jeong JS, Lee YC. Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation. J Allergy Clin Immunol 132 : 1397–1408, 2013. doi:10.1016/j.jaci.2013.08.041. 24161747
33. Miao K, Zhang L, Pan T, Wang Y. Update on the role of endoplasmic reticulum stress in asthma. Am J Transl Res 12 : 1168–1183, 2020. 32355534
34. Marciniak SJ. Endoplasmic reticulum stress in lung disease. Eur Respir Rev 26 : 170018, 2017. doi:10.1183/16000617.0018-2017. 28659504
35. Ventoso I, Kochetov A, Montaner D, Dopazo J, Santoyo J. Extensive translatome remodeling during ER stress response in mammalian cells. PLoS One 7 : e35915, 2012. doi:10.1371/journal.pone.0035915. 22574127
36. Kim HJ, Jeong JS, Kim SR, Park SY, Chae HJ, Lee YC. Inhibition of endoplasmic reticulum stress alleviates lipopolysaccharide-induced lung inflammation through modulation of NF-κB/HIF-1α signaling pathway. Sci Rep 3 : 1142, 2013. doi:10.1038/srep01142. 23359618
37. Tam AB, Mercado EL, Hoffmann A, Niwa M. ER stress activates NF-κB by integrating functions of basal IKK activity, IRE1 and PERK. PLoS One 7 : e45078, 2012. doi:10.1371/journal.pone.0045078. 23110043
38. Hu H, Tian M, Ding C, Yu S. The C/EBP homologous protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol 9 : 3083, 2018. doi:10.3389/fimmu.2018.03083. 30662442
39. Kato A, Favoreto S Jr, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 179 : 1080–1087, 2007. doi:10.4049/jimmunol.179.2.1080. 17617600
40. Hansbro PM, Kim RY, Starkey MR, Donovan C, Dua K, Mayall JR, Liu G, Hansbro NG, Simpson JL, Wood LG, Hirota JA, Knight DA, Foster PS, Horvat JC. Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma. Immunol Rev 278 : 41–62, 2017. doi:10.1111/imr.12543. 28658552
41. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J 19 : 68–75, 2002. doi:10.1183/09031936.02.00226302. 11852895
